Stock Events

Stock Events

Apellis Pharmaceuticals (APLS) Q3 2025 Earnings

31JulConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.74

-0.59

-0.44

-0.29

Details

Expected EPS

-0.465485

Actual EPS

-0.33

Surprise EPS

0.14

Surprise Percent

+29.11%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -0.33 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.